Delzicol FDA Approval History
Delzicol (mesalamine) is an aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.
Development Timeline for Delzicol
|Feb 6, 2013||Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.